Phase II Study of Preoperative Bevacizumab and Trastuzumab Administered With ABI-007 and Carboplatin in HER2 Overexpressing Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Trastuzumab (Primary) ; Carboplatin; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2011 Status changed from active, no longer recruiting to completed.as reported by ClinicalTrials.gov.
- 19 Jul 2011 Planned End Date changed from 1 Aug 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.